Pediatric and Young Adult Image-Guided Percutaneous Bone Biopsy-A New Standard of Care?
hosted by Dr. Sophia Schermerhorn · StayCurrentMD
Part of
Sarcoma (Ewing/Rhabdo) 36 items
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
More about pediatric bone tumors
same diagnosisOnly a few other public items share this diagnosis — nothing to add yet.
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
What the experts said
The study evaluated 169 biopsies in 141 patients over a 10-year period at a single institution.
Nearly 90% of the biopsies were core-needle biopsies.
All biopsies were performed with image guidance, most commonly CT, sometimes combined with fluoroscopy and ultrasound.
All biopsies were performed by interventional radiologists.
97.9% of biopsies were diagnostic.
Only 3 patients required repeat biopsy.
There was one patient with transient sciatic nerve paresis, which resolved.
The complication rate was 0.7%.
The approach provided sufficient tissue for histology, immunostains, and molecular studies.
Immunostains and molecular studies are increasingly essential for modern risk stratification and targeted therapy.
Image-guided percutaneous biopsy should be strongly considered the diagnostic modality of choice for pediatric bone and soft tissue tumors.